Table 1.
Patient demographics of postpartum patients identified for Hepatitis C treatment
| Characteristics | N |
|---|---|
| Maternal age (range in years) | 31 (23–40) |
| Race (%) | |
| White | 34 (100) |
| Ethnicity (%) | |
| Non-Hispanic or Latino | 34 (100) |
| Prenatal care (%) | |
| Multidisciplinary SUD treatment | 22 (65) |
| OB clinic | 3 (9) |
| Outside prenatal care | 5 (15) |
| Prenatal care scant or none | 4 (12) |
| Active substance usea (%) | 9 (26) |
| Received MOUD (%) | 24 (71) |
Sample N = 34
SUD substance use disorder, MOUD medications for opioid use disorder (buprenorphine, buprenorphine/naloxone, methadone)
aActive substance use defined as a positive urine drug screen on presentation to labor and delivery and prior to receiving any analgesic medication